These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18032782)

  • 1. New insights into PTEN.
    Tamguney T; Stokoe D
    J Cell Sci; 2007 Dec; 120(Pt 23):4071-9. PubMed ID: 18032782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN in Hereditary and Sporadic Cancer.
    Ngeow J; Eng C
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31570378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into PTEN regulation mechanisms and its potential function in targeted therapies.
    Zhang P; Chen JH; Guo XL
    Biomed Pharmacother; 2012 Oct; 66(7):485-90. PubMed ID: 22902055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN function: how normal cells control it and tumour cells lose it.
    Leslie NR; Downes CP
    Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INPP4B: the new kid on the PI3K block.
    Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
    Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer, PTEN and the PI-3 kinase pathway.
    Parsons R
    Semin Cell Dev Biol; 2004 Apr; 15(2):171-6. PubMed ID: 15209376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific Pten deletion protects against insulin resistance and diabetes.
    Wijesekara N; Konrad D; Eweida M; Jefferies C; Liadis N; Giacca A; Crackower M; Suzuki A; Mak TW; Kahn CR; Klip A; Woo M
    Mol Cell Biol; 2005 Feb; 25(3):1135-45. PubMed ID: 15657439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
    Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN and cancer.
    Parsons R; Simpson L
    Methods Mol Biol; 2003; 222():147-66. PubMed ID: 12710685
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
    Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
    Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.